// App-Quantinova.ai

650 : Are circulating tumor cells (CTCs) a feasible tool for predicting disease recurrence and survival in nonmetastatic (M0) colorectal cancer (CRC)?

Researchers

Presenter

  • Francesca Bergamo

Principal Investigators

  • Elisabetta Rossi

  • Salvatore Pucciarelli

  • Francesca Battaglin

  • Paola Toppan

  • Pasquale Fiduccia

  • Alberto Amadori

  • Sara Lonardi

  • Rita Zamarchi

Medical Centers

  • Unita Sperimentazioni Cliniche e Biostatistica, Istituto Oncologico Veneto, IRCCS, Padova, Italy

  • U.O.C. Immunologia e Diagnostica Molecolare - Oncologica Istituto Oncologico Veneto - IRCCS, Padua, Italy

  • Dipartimento di Oncologia Clinica e Sperimentale, UOC Oncologia Medica I, Istituto Oncologico Veneto-IRCCS, Padova, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved